Delayed arm-cuff conditioning to reduce lung complications after non-cardiac, non-thoracic surgery in older adults

The Effect of Delayed Remote Ischemic Preconditioning on Postoperative Pulmonary Complications in Elderly Patients Undergoing Non-Cardiac Thoracic Surgery

Not applicable Interventional Shanghai Geriatric Medical Center · NCT07208500

This study will test whether inflating a blood-pressure cuff on the arm in short cycles about 24 hours before surgery can lower the risk of lung problems after surgery in people aged 65 and older.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment390 (estimated)
Ages65 Years and up
SexAll
SponsorShanghai Geriatric Medical Center Academic / other
Drugs / interventionschemotherapy, immunotherapy
Locations1 site (Shanghai)
Trial IDNCT07208500 on ClinicalTrials.gov

What this trial studies

This interventional study applies delayed remote ischemic preconditioning (RIPC) — repeated short inflations and deflations of an upper-arm cuff performed 24 hours before surgery — and compares it to a low-pressure sham procedure. The active RIPC protocol inflates the cuff to about 200 mmHg for 5 minutes followed by 5 minutes of deflation, repeated four times. Participants are assigned to receive either the RIPC or the sham procedure before undergoing non-cardiac, non-thoracic operations lasting 1–3 hours, and will be followed for postoperative pulmonary complications such as pneumonia or respiratory failure. The trial enrolls older adults (65+) meeting ASA I–II and BMI 18–30 kg/m², with prespecified medical exclusions, and is conducted at Shanghai Geriatric Medical Center.

Who should consider this trial

Good fit: Ideal candidates are adults aged 65 or older with ASA physical status I–II, BMI 18–30 kg/m², scheduled for a 1–3 hour non-cardiac, non-thoracic operation who can attend a preoperative cuff procedure 24 hours before surgery.

Not a fit: Patients with significant preoperative respiratory dysfunction, moderate-to-severe heart failure (NYHA II–IV), peripheral vascular disease of the upper limb, recent chemotherapy/radiotherapy/immunotherapy, recent systemic infection, coagulation disorders, or recent use of antibiotics, NSAIDs, or corticosteroids are unlikely to benefit and are excluded.

Why it matters

Potential benefit: If successful, this simple, noninvasive, and low-cost arm-cuff procedure could reduce postoperative lung complications and related recovery time for older surgical patients.

How similar studies have performed: Remote ischemic preconditioning has shown organ-protective effects in some cardiac and vascular settings, but evidence for preventing postoperative lung complications is limited and results have been mixed.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Elderly patients aged 65 years and above undergoing non-cardiac and non-thoracic surgery; operation time of 1-3 hours; American Society of Anesthesiologists (ASA) classification from I to II; BMI of 18-30 kg/m².

Exclusion Criteria:

* NYHA cardiac function classification is grade II to IV; there is severe respiratory dysfunction before surgery; there is a history of coagulation dysfunction diseases; chemotherapy, radiotherapy or immunotherapy have been received within 3 months; there is systemic or local active infection; there is peripheral vascular disease affecting upper limb blood vessels; antibiotics, non-steroidal anti-inflammatory drugs, or corticosteroids have been taken within the past 3 months.

Where this trial is running

Shanghai

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Pulmonary Complications in Surgical Patients
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.